396 filings
8-K
BIOCQ
Biocept Inc
11 Dec 19
Biocept Announces Pricing of $10.0 Million Underwritten Public Offering
12:00am
424B4
BIOCQ
Biocept Inc
11 Dec 19
Prospectus supplement with pricing info
12:00am
EFFECT
BIOCQ
Biocept Inc
10 Dec 19
Notice of effectiveness
12:15am
S-1/A
BIOCQ
Biocept Inc
IPO registration (amended)
5 Dec 19
9:46pm
S-1/A
BIOCQ
Biocept Inc
IPO registration (amended)
4 Dec 19
9:11pm
CORRESP
77h0ky8
4 Dec 19
Correspondence with SEC
12:00am
CORRESP
nujlno 56wo
4 Dec 19
Correspondence with SEC
12:00am
8-K
r3h 8tw5s
13 Nov 19
Biocept Reports Third Quarter 2019 Financial Results
4:15pm
UPLOAD
4tufzsqq7kd1bn
5 Nov 19
Letter from SEC
12:00am
8-K
czj7ot4
27 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
S-8
6cuu09av3mwjbn3i ms9
15 Aug 19
Registration of securities for employees
12:00am
8-K
9tqt2s2
12 Aug 19
Biocept Reports Second Quarter 2019 Financial Results
4:20pm
8-K
dmllvg 40gk
18 Jul 19
Entry into a Material Definitive Agreement
6:04am
8-K
gm461xkw c2z
19 Jun 19
Departure of Directors or Certain Officers
5:17pm
4
tle 8p7630
19 Jun 19
BIOCEPT / Michael W. Nall ownership change
4:24pm